What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?
CONCLUSIONS: Long-acting PrEP holds promise for reducing HIV incidence, but its implications for the HBV epidemic, particularly in sub-Saharan Africa, should not be overlooked.PMID:38444112 | DOI:10.1002/jia2.26218
Source: Journal of the International AIDS Society - Category: Infectious Diseases Authors: Amir M Mohareb Menan G érard Kouamé Marcellin Nouaman Arthur Y Kim Joseph Larmarange Anne M Neilan Karine Lacombe Kenneth A Freedberg Anders Boyd Patrick Coffie Emily P Hyle Source Type: research
More News: African Health | AIDS Vaccine | Epidemics | Epidemiology | Hepatitis | Hepatitis B | Hepatitis Vaccine | HIV AIDS | Infectious Diseases | Laboratory Medicine | Men | Vaccines | Viread